Tue.Sep 03, 2024

article thumbnail

In Europe, shortages of Novo Nordisk's Ozempic to persist into Q4: letter

Fierce Pharma

Late last year, Novo Nordisk responded to a growing shortage of popular Ozempic with a plan to cut down on production of its older diabetes med Victoza to make room for more Ozempic. | The company and the European Medicines Agency warned European healthcare providers to continue limiting new patient prescriptions until the shortages let up.

article thumbnail

HDA 2024 Traceability Seminar: Legal Advice for DSCSA Compliance Teams

Pharmaceutical Commerce

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ilisa B.G. Bernstein, President of Bernstein Rx Solutions, LLC, highlights the hard-hitting points that she anticipated will be covered during her session at the 2024 HDA Traceability Seminar.

Pharma 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Dr. Reddy's banned from China's drug procurement program after inspectors turn up manufacturing problems

Fierce Pharma

Dr. Reddy’s has been cut off from China’s bulk-buy drug procurement program after an inspection turned up “serious defects” in the company’s manufacturing operations. | Following a remote inspection of a Dr. Reddy’s formulations production plant, China’s National Medical Products Administration has suspended the import, sale and use of the Indian drugmaker’s atomoxetine hydrochloride capsules for ADHD.

article thumbnail

Health Literacy Is Not a Multi-Language Insert

MedCity News

We must empower health plan members with culturally and linguistically-relevant information about their benefits and health – tools that in turn encourage them to adopt a proactive and informed approach to their well-being. The post Health Literacy Is Not a Multi-Language Insert appeared first on MedCity News.

Education 104
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Scilex's Semnur Pharmaceuticals to go public through $2.5B SPAC merger as it advances sciatica prospect

Fierce Pharma

Semnur Pharmaceuticals, which is working on a non-opioid prospect for sciatica, has agreed to merge with special purpose acquisition company Denali Capital Acquisition Corp. | Semnur Pharmaceuticals is following in its parent company Scilex's footsteps with a special purpose acquisition company (SPAC) merger.

article thumbnail

UAE MoHAP and Novo Nordisk partner for obesity management

Pharmaceutical Technology

The UAE has partnered with Novo Nordisk Pharma Gulf to develop a national scientific guide for obesity management and weight control.

More Trending

article thumbnail

Why the Importer of Record (IoR) is vital in the clinical supply chain ­­

Pharmaceutical Technology

In clinical supplies, the Importer of Record (IoR) provides a critical service in facilitating logistics and easing the burden for sponsors.

104
104
article thumbnail

Illumina avoids hefty EU fine over Grail merger

pharmaphorum

EU had no grounds to probe Illumina's takeover of Grail, says ECJ, but while spinoff has already taken place Illumina can now avoid a €432m fine

115
115
article thumbnail

Skyline wins orphan drug designation for retinitis pigmentosa gene therapy

Pharmaceutical Technology

There are currently no approved treatments that can halt or reverse photoreceptor degeneration in patients with retinitis pigmentosa.

article thumbnail

Eliminating the AI ‘Black Box’ to Make Clinical Data Usable

MedCity News

As Gen AI continues to mature, there will be ways to employ these technologies thoughtfully and safely in healthcare today. The key is to continue to embrace new breakthroughs – with strong guardrails for safety, privacy and transparency. The post Eliminating the AI ‘Black Box’ to Make Clinical Data Usable appeared first on MedCity News.

Safety 87
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Unpacking the High Cost of GLP-1 Drugs

Pharmaceutical Commerce

How can industry stakeholders ensure the quality and supply chain security of existing product?

111
111
article thumbnail

Sounder Benefits Launches To Advance Employee Health Benefits

MedCity News

Sounder Benefits, which was built at Redesign Health, launched last week with $7.5 million in funding. The company is a health tech startup specializing in benefits for employers with fewer than 1,000 employees. The post Sounder Benefits Launches To Advance Employee Health Benefits appeared first on MedCity News.

article thumbnail

Digital NHS health checks will start in England next year

pharmaphorum

A digital version of the NHS Health Check offered to older people in the UK will be piloted in some areas of England early next year, according to the government.The Department of Health and Social Care (DHSC) has said the digital alternative to the current system of in-person health checks will be ready for testing in early 2025, with pilots planned for Norfolk, Medway, and Lambeth in London.

103
103
article thumbnail

FDA adcomm reform talks heat up

PharmaVoice

As the agency considers eliminating adcomm votes from the approval process, members vie to have their voices heard.

FDA 81
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Data builds behind Valneva, Pfizer's Lyme disease vaccine

pharmaphorum

New data for Valneva and Pfizer's Lyme disease vaccine bolsters the case for the shot as the results of a phase 3 programme are awaited.

110
110
article thumbnail

Improving upstream fermentation with end-to-end automation

European Pharmaceutical Review

Researchers from Sanofi Vaccines have developed an automated end-to-end process that enables real-time in-line monitoring and control of metabolites during bioprocess development. Utilising process analytical technology (PAT) and quality by design-focused principles, the metabolite feed-back control system offers an improved upstream fermentation process in stirred-tank fermentors.

article thumbnail

Vaxcyte's pneumococcal vaccine win points to Prevnar battle

pharmaphorum

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD.Just-reported data from that study has shown that Vaxcyte's VAX-31 shot was able to stimulate a strong immune response against all 31 serotypes of Streptococcus pneumoniae included in the formulation, in adults aged 50 and over.

90
article thumbnail

Pharma Pulse 9/3/24: CrowdStrike VP to Testify on IT Outage, Embracing FSPs & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 105
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Advanz Pharma's bid to keep Ocaliva on EU market fails

pharmaphorum

EU follows through on plan to revoke approval for Advanz Pharma's Ocaliva for rare disease primary biliary cholangitis (PBC)

Pharma 101
article thumbnail

Strategic Decarbonization

PharmaTech

Bio/pharma companies should be approaching their decarbonization journey as a strategic business move for the future as industry stakeholders are placing greater value on sustainability.

Pharma 52
article thumbnail

3D-printed tumours could aid cancer therapy R&D

pharmaphorum

Researchers in the Netherlands have developed 3D-printed 'mini tumours' that behave like real cancerous tissue and can be used to test new treatments, including drug and cell-based immunotherapies.The team from the Leiden Academic Centre for Drug Research say the models are an alternative to the current approach of testing immunotherapies by culturing tumour cells in a petri dish alongside T cells, or drugs such as antibodies, and seeing how they interact.

80
article thumbnail

Camzyos Demonstrates Efficacy, Safety Treating Symptomatic Obstructive Hypertrophic Cardiomyopathy

PharmExec

Results from the Phase III EXPLORER-LTE study found that Camzyos maintained effectiveness in treating symptomatic obstructive hypertrophic cardiomyopathy after 3.5 years of treatment.

Safety 52
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Leveraging Showpad for Pharmaceutical Sales Teams: A Comprehensive Guide

Infuse Medical

In today’s rapidly evolving digital landscape, pharmaceutical sales teams face unparalleled challenges. The complexity of managing vast amounts of product information, engaging with increasingly informed healthcare professionals, and adhering to strict regulatory requirements has made traditional sales methods less effective. As a result, sales reps often struggle to deliver personalized, impactful presentations that resonate with their audience.

article thumbnail

RegenxBio touts positive data for rare disease drug RGX-121

Pharmaceutical Technology

RGX-121 has been evaluated in the Phase I/II/III CAMPSIITE study as a one-time gene therapy treatment for Hunter syndrome.

59
article thumbnail

Responding to Mpox

PharmaTech

A coordinated and international response is needed to help control the latest mpox outbreak in Africa.

64
article thumbnail

Lumryz Demonstrates Superiority Over Oxybate Treatments in Narcolepsy

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Insurance Status, Survival Outcomes Linked in Patients With Diffuse Large B-Cell Lymphoma

Pharmacy Times

Patients with DLBCL on Medicaid had worse survival outcomes than those on commercial insurance, but there were no statistically significant differences in survival between races.

article thumbnail

Understanding the Current State of M&A: Q&A with Cheryl Reicin

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

ESC 2024: Beta blocker treatment paradigm shifts for myocardial infarction

Pharmaceutical Technology

New data provides more evidence on choosing the ideal approach for prescription of beta blockers for myocardial infarction.

article thumbnail

Pharma Pulse 9/3/24: Current Trends in Patient Reimbursement, Strengthening Flu Defenses & more

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A